Journal of the Egyptian National Cancer Institute

SpringerOpen

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Journal of the Egyptian National Cancer Institute is an open-access journal published by SpringerOpen in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared review time at DOAJ: 11 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SpringerOpen
ISSN
1110-0362 · 2589-0409
Country
United Kingdom
Languages
english
Access
Open access
Articles in DOAJ
539
Declared review time
11 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2016-05-10
  • MEDLINE · 2005-01-01
  • PUBMED · 2016-01-02
Indexing
DOAJ · MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
11 weeks
Actual review time (measured)
138 days received→accepted — computed from PubMed (n=99)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

539

Most recent article

last month

Average review time (journal-declared via DOAJ)

11weeks

Works in OpenAlex

677

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

36

i10-index

212

From OpenAlex open data (CC0).

Editorial & policy11
Last DOAJ review date
2026-03-17
Added to DOAJ
2016-05-10
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9424566
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Cancer Immunotherapy and Biomarkers
  • Head and Neck Cancer Studies
  • Cancer Immunotherapy and Biomarkers
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Head and Neck Cancer Studies
Show all subjects (50)
  • Endometrial and Cervical Cancer Treatments
  • Endometrial and Cervical Cancer Treatments
  • Sarcoma Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Sarcoma Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis
  • Bladder and Urothelial Cancer Treatments
  • Acute Lymphoblastic Leukemia research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Breast Lesions and Carcinomas
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Cancer Cells and Metastasis
  • Breast Lesions and Carcinomas
  • Thyroid Cancer Diagnosis and Treatment
  • MicroRNA in disease regulation
  • Acute Myeloid Leukemia Research
  • Cancer Cells and Metastasis
  • Thyroid Cancer Diagnosis and Treatment
  • MicroRNA in disease regulation
  • Lung Cancer Treatments and Mutations
  • Brain Metastases and Treatment
  • Lung Cancer Treatments and Mutations
  • Breast Implant and Reconstruction
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Brain Metastases and Treatment
  • Breast Implant and Reconstruction
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Colorectal Cancer Surgical Treatments
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Colorectal Cancer Surgical Treatments
  • Cholangiocarcinoma and Gallbladder Cancer Studies

Keywords (DOAJ)

  • cancer
  • chemotherapy
  • neoplasia
  • oncology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: